OSE IMMUNOTHERAPEUTICS SA — Ethics & Boards

Corporation with Board of Directors
Nantes, France
Closing date: December 31
Date of the Last Annual General Meeting: June 25, 2025
- CAC All - Tradable
- E&B Pharmaceuticals & Biotechnology

Ethics & Boards Databank reserved for subscribers

Discover our services Book a demo

Governance leadership structure

Board of Directors

Didier HOCH
Chair
Since over 1 year

Other directorships

12 voting members without any non-voting

Directors
average seniority 3.9 years
3.9 years for elected by shareholders

Directors
average age - years
- years for elected by shareholders

Chair and CEO roles are separated:
Is the Nomination committee Chair independent?	No
Is there a 2/3 majority of independent Directors in the Audit Committee?	Yes

7 members

Management Team

Nicolas POIRIER
Chief Executive Officer
Since over 3 years
Other directorships

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.